Works matching IS 15330028 AND DT 2010 AND VI 9 AND IP 2

Results: 17

A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 95, doi. 10.3816/CCC.2010.n.013

By:

Hecht, J. Randolph;
Pillai, Madhavan;
Gollard, Russell;
Heim, William;
Swan, Forrest;
Patel, Ravi;
Dreiling, Lyndah;
Mo, May;
Malik, Imtiaz

Publication type:

Article

The 2010 American Society of Clinical Oncology gastrointestinal Cancers Symposium, Orlando, FL; January 22-24, 2010.

Published in:

2010

By:

Quill T

Publication type:

Journal Article

Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon Cancer (GERCOR C96.1)

Published in:

2010

By:

Baumgaertner I;
Quinaux E;
Khalil A;
Louvet C;
Buyse M;
de Gramont A;
André T;
GERCOR Group

Publication type:

Journal Article

Chemotherapy resistance and retreatment: a dogma revisited.

Published in:

2010

By:

Naing A;
Kurzrock R

Publication type:

Journal Article

Nonoperative Management of Rectal Cancer: Current Perspectives.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 83, doi. 10.3816/CCC.2010.n.011

By:

Higgins, Kristin A.;
Willett, Christopher G.;
Czito, Brian G.

Publication type:

Article

Clinical trials list. Selected trials in gastrointestinal stromal, gastro-esophageal, and hepatocellular cancer.

Published in:

2010

By:

Chu E

Publication type:

Journal Article

The Src Family of Protein Tyrosine Kinases: A New and Promising Target for Colorectal Cancer Therapy.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 89, doi. 10.3816/CCC.2010.n.012

By:

Lieu, Christopher;
Kopetz, Scott

Publication type:

Article

Chemotherapy Resistance and Retreatment: A Dogma Revisited.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. E1, doi. 10.3816/CCC.2010.n.026

By:

Naing, Aung;
Kurzrock, Razelle

Publication type:

Article

Transient Carcinoembryonic Antigen Elevations During Adjuvant Chemotherapy for Colorectal Cancer Reflect the Burden of Residual Micrometastatic Disease.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 108, doi. 10.3816/CCC.2010.n.015

By:

Yau, Thomas;
Wong, Hilda;
Chan, Pierre;
Chan, Tracy;
Mak, Joyce;
Epstein, Richard J.

Publication type:

Article

Selected Trials in Gastrointestinal Stromal, Gastro-Esophageal, and Hepatocellular Cancer.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 126

By:

CIG Media Group

Publication type:

Article

Assessing the Quality of Initial Consultations Regarding Adjuvant Colon Cancer Therapy.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 113, doi. 10.3816/CCC.2010.n.016

By:

Sanoff, Hanna K.;
Goldberg, Richard M.;
Pignone, Michael P.

Publication type:

Article

A Phase I Study of Bortezomib in Combination With Standard 5-Fluorouracil and External-Beam Radiation Therapy for the Treatment of Locally Advanced or Metastatic Rectal Cancer.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 119, doi. 10.3816/CCC.2010.n.017

By:

O'Neil, Bert H.;
Raftery, Laura;
Calvo, Benjamin F.;
Chakravarthy, A. Bapsi;
Ivanova, Anastasia;
Myers, Michael O.;
Kim, Hong Jin;
Chan, Emily;
Wise, Paul E.;
Caskey, Laura S.;
Bernard, Stephen A.;
Sanoff, Hanna K.;
Goldberg, Richard M.;
Tepper, Joel E.

Publication type:

Article

A Phase II Trial of FOLFOX6 and Cetuximab in the First-line Treatment of Patients With Metastatic Colorectal Cancer.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 102, doi. 10.3816/CCC.2010.n.014

By:

Boccia, Ralph V.;
Cosgriff, Thomas M.;
Headley, David L.;
Badarinath, Suprith;
Dakhil, Shaker R.

Publication type:

Article

Comparison of the Levogyre and Dextro-Levogyre Forms of Leucovorin in a Phase III Trial of Bimonthly LV5FU2 Versus Monthly 5-Fluorouracil and High-Dose Leucovorin for Patients With Stage II and III Colon Cancer (GERCOR C96.1).

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. E5, doi. 10.3816/CCC.2010.n.027

By:

Baumgaertner, Isabelle;
Quinaux, Emmanuel;
Khalil, Ahmed;
Louvet, Christophe;
Buyse, Marc;
de Gramont, Aimery;
André, Thierry

Publication type:

Article

The 2010 American Society of Clinical Oncology Gastrointestinal Cancers Symposium.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 77, doi. 10.3816/CCC.2010.n.010

By:

Quill, Timothy

Publication type:

Article

Colorectal Cancer Screening and Early Detection.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 75, doi. 10.3816/CCC.2010.n.009

By:

Chu, Edward

Publication type:

Article

CLINICAL Colorectal Cancer.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. 69

By:

CIG Media Group

Publication type:

Article